Tricida (Tricida) Effective Interest Rate on Debt % : 3.80% (As of Sep. 2022)

View and export this data going back to 2018. Start your Free Trial

What is Tricida Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Tricida's annualized positive value of Interest Expense for the quarter that ended in Sep. 2022 was $7.91 Mil. Tricida's average total debt for the quarter that ended in Sep. 2022 was $208.12 Mil. Therefore, Tricida's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2022 was 3.80%.

Tricida Effective Interest Rate on Debt % Historical Data

The historical data trend for Tricida's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tricida Effective Interest Rate on Debt % Chart

Tricida Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

8.24

10.81

13.21

10.00

Tricida Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															11.52	11.58	4.51	3.79	3.80

Competitive Comparison of Tricida's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Tricida's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tricida's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tricida's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Tricida's Effective Interest Rate on Debt % falls into.

Tricida Effective Interest Rate on Debt % Calculation

Tricida's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2021 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2020 )	+	Total Debt (A: Dec. 2021 ))	/ count )
=	-1 * -17.602	/	( (210.433	+	141.544)	/ 2 )
=	-1 * -17.602	/	175.9885
=	10.00 %

where

	Total Debt (A: Dec. 2020 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	208.354	+	2.079
=	210.433

	Total Debt (A: Dec. 2021 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	138.808	+	2.736
=	141.544

Tricida's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2022 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2022 )	+	Total Debt (Q: Sep. 2022 ))	/ count )
=	-1 * -7.912	/	( (208.242	+	207.995)	/ 2 )
=	-1 * -7.912	/	208.1185
=	3.80 %

where

	Total Debt (Q: Jun. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	205.465	+	2.777
=	208.242

	Total Debt (Q: Sep. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	205.198	+	2.797
=	207.995

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2022) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Tricida (OTCPK:TCDAQ) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Tricida Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Tricida's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Tricida (Tricida) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tricida Inc (OTCPK:TCDAQ) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7000 Shoreline Court, Suite 201, South San Francisco, CA, USA, 94080

Website

https://www.tricida.com

Tricida Inc is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic kidney disease through the treatment of metabolic acidosis.

Executives

David P Bonita	director, 10 percent owner	C/O ORBIMED ADVISORS LLC, 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Advisors Llc	director, 10 percent owner	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Robert J Alpern	director	YALE SCHOOL OF MEDICINE, 333 CEDAR STREET, C203 SHM, NEW HAVEN CT 06520
Venrock Healthcare Capital Partners Ii, L.p.	10 percent owner	7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Sibling Capital Fund Ii-b L.p.	10 percent owner, other: *possible member of 10% group	2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Sibling Capital Ventures Ii Llc	10 percent owner, other: *possible member of 10% group	2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Brian M. Isern	10 percent owner, other: *possible member of 10% group	2033 6TH AVE., SUITE 330, SEATTLE WA 98121
Sibling Capital Fund Ii-c L.p.	10 percent owner, other: *possible member of 10% group	2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Sibling Capital Ventures Iii Llc	10 percent owner, other: *possible member of 10% group	2033 6TH AVE, SUITE 330, SEATTLE WA 98121
Sibling Capital Fund Ii-a L.p.	10 percent owner, other: possible member of 10% group	500 YALE AVE N, SEATTLE WA 98109
Vhcp Management Eg, Llc	10 percent owner	3340 HILLVIEW AVENUE, PALO ALTO CA 94304
Venrock Healthcare Capital Partners Eg, L.p.	10 percent owner	3340 HILLVIEW AVENUE, PALO ALTO CA 94304
Vhcp Co-investment Holdings Iii, Llc	10 percent owner	7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Vhcp Management Iii, Llc	10 percent owner	7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Venrock Healthcare Capital Partners Iii, L.p.	10 percent owner	530 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10036